全文获取类型
收费全文 | 2126篇 |
免费 | 107篇 |
国内免费 | 7篇 |
专业分类
耳鼻咽喉 | 8篇 |
儿科学 | 65篇 |
妇产科学 | 64篇 |
基础医学 | 221篇 |
口腔科学 | 16篇 |
临床医学 | 163篇 |
内科学 | 525篇 |
皮肤病学 | 11篇 |
神经病学 | 199篇 |
特种医学 | 155篇 |
外科学 | 227篇 |
综合类 | 12篇 |
一般理论 | 2篇 |
预防医学 | 82篇 |
眼科学 | 7篇 |
药学 | 205篇 |
中国医学 | 14篇 |
肿瘤学 | 264篇 |
出版年
2023年 | 12篇 |
2022年 | 38篇 |
2021年 | 34篇 |
2020年 | 36篇 |
2019年 | 51篇 |
2018年 | 57篇 |
2017年 | 37篇 |
2016年 | 29篇 |
2015年 | 54篇 |
2014年 | 72篇 |
2013年 | 78篇 |
2012年 | 152篇 |
2011年 | 163篇 |
2010年 | 89篇 |
2009年 | 73篇 |
2008年 | 109篇 |
2007年 | 103篇 |
2006年 | 103篇 |
2005年 | 90篇 |
2004年 | 115篇 |
2003年 | 86篇 |
2002年 | 83篇 |
2001年 | 49篇 |
2000年 | 65篇 |
1999年 | 37篇 |
1998年 | 22篇 |
1997年 | 16篇 |
1996年 | 16篇 |
1995年 | 20篇 |
1994年 | 15篇 |
1993年 | 14篇 |
1992年 | 29篇 |
1991年 | 26篇 |
1990年 | 33篇 |
1989年 | 21篇 |
1988年 | 24篇 |
1987年 | 13篇 |
1986年 | 16篇 |
1985年 | 16篇 |
1984年 | 18篇 |
1983年 | 12篇 |
1982年 | 7篇 |
1980年 | 9篇 |
1979年 | 12篇 |
1976年 | 7篇 |
1975年 | 10篇 |
1974年 | 10篇 |
1973年 | 6篇 |
1969年 | 6篇 |
1967年 | 6篇 |
排序方式: 共有2240条查询结果,搜索用时 15 毫秒
81.
S B Halstead N J Marchette A R Diwan N E Palumbo R Putvatana L K Larsen 《The American journal of tropical medicine and hygiene》1984,33(4):672-678
Two strains of primary dog kidney-passaged dengue (DEN) 4 (H-241) virus cloned by terminal dilution (PDK 24-TD3 and 35-TD3) were propagated in fetal rhesus lung (FRhL) cells to produce candidate vaccine virus seeds. Both serial passage and prolonged replication of PDK 24-TD3 in FRhL resulted in appearance of medium and large plaques in LLC-MK2 assays. When picked, these plaques proved to contain temperature-resistant, monkey-virulent revertants. Serial passage and prolonged replication of PDK 24-TD3 in LLC-MK2 cells did not result in reversion; but, prolonged replication in PDK cells did. Passage of PDK 35-TD3 in FRhL cells resulted in appearance of medium size plaques which, when picked, yielded temperature sensitive (ts) (38.5 degrees C) viruses of low monkey-virulence. Because of its stability in monkeys and FRhL cells, reduced monkey virulence and ts property. PDK 35-TD3 is a promising candidate for trial in man. 相似文献
82.
E Palumbo N Svetoni M Casini T Spargi G Biagi T Lanzetta 《Giornale italiano di cardiologia》1984,14(5):381-382
Twelve patients with ventricular arrhythmias were given 300-900 mg oral of propafenon daily. We have obtained VT's suppression in 6 of 8 cases (75%) and "complex" VEB's suppression or significant reduction in 6 of 10 cases (60%). Total VEB have been strongly reduced (-91,2%) in 7 of 12 patients (58,3%). The effects of Propafenon on electrocardiographic intervals have not been significant at lower doses and only with 900 mg we have noted a significant (p less than 0,05) lengthening of the P-R (+27,1%) and QTc (+10,2%) intervals. Propafenon has never caused important negative inotropic effects. These results have been confirmed during a follow-up period of 5-19 months. In conclusion we believe that Propafenon must be considered a highly efficient drug for the treatment and prevention of refractory ventricular arrhythmias. 相似文献
83.
Francesco Formica Orazio Ferro Pierpaolo Greco Antonello Martino Daniela Gastaldi Giovanni Paolini 《European journal of cardio-thoracic surgery》2004,26(6):1141-1148
Objective: In order to reduce remote cardiac events associated with graft occlusions, arterial conduits are being increasingly utilized in coronary artery bypass grafting (CABG). While the internal thoracic artery (ITA) is the graft of choice for CABG, it is sometimes difficult or impossible to obtain a complete arterial revascularization only with ITAs in three-vessel diseases. We present our experience with total arterial myocardial revascularization with bilateral internal thoracic artery (BITA) and right gastroepiploic artery (rGEA). Methods: From April 1994 to January 2004, 174 patients (165 male, mean age 55.9±7.4) underwent coronary artery bypass procedure with exclusive use of BITA and rGEA. Left ventricular ejection fraction ranged from 20 to 68% (mean 55.9±6.8%). Seven patients (4%) had poor ejection fraction (<0.30), 23 (13, 2%) had acute myocardial infarction, 14 (8%) had left main disease. The mean CPB time was 96.9±15.7 min and the mean cross clamping time was 70±14.2 min. The mean number of distal anastomoses was 3.3±0.5 per patient. Results: Early mortality was 1.7%. The patients were followed for up to 9 years (mean follow-up time 6.3±2.6 years). Actuarial freedom from cardiac death (including hospital death) was 97.6%, at 9 years after the operation. Actuarial freedom from angina and cardiac events at 9 years was 79, 5% and 77, 6%, respectively. No perioperative myocardial infarction occurred. None of the patients needed a redo-CABG after leaving the hospital. Conclusions: This study indicates that the myocardial revascularization in young patients with three-vessel disease using exclusively pedicle BITA and rGEA provides excellent 9-year patient survival and improvement in terms of freedom from return of angina pectoris and freedom from any cardiac-related event. These results encourage the more extensive use of BITA and rGEA in selected patients with three-vessel coronary disease. 相似文献
84.
Massa R Palumbo C Cavallaro T Panico MB Bei R Terracciano C Rizzuto N Bernardi G Modesti A 《Muscle & nerve》2006,33(3):342-349
Axon-derived neuregulins (NRGs) are a family of growth factors whose binding to ErbB tyrosine kinase receptors promotes the maturation, proliferation and survival of Schwann cells (SCs). Correct NRG/ErbB signaling is essential for the homeostasis of axonal-glial complexes and seems to play a role in peripheral nerve repair. The potential involvement of ErbB receptors in human peripheral neuropathies has not been clarified. Therefore, we assessed the immunoreactivity for EGFR (ErbB1), ErbB2, and ErbB3 in nerve biopsies from patients with different forms of Charcot-Marie-Tooth disease, type 1, (CMT1), as compared to others with inflammatory neuropathies and controls. The most notable changes consisted in the overexpression of ErbB2 and ErbB3 by SCs of nerves from CMT1A patients. These findings are consistent with an impairment of SC differentiation and expand the molecular phenotype of CMT1A. The upregulation of these receptors may play a role in the inhibition of myelination or in the promotion of recurrent demyelination and axonal damage. 相似文献
85.
Maria Ricci Agostino Chiaravalloti Alessandro Martorana Giacomo Koch Vincenzo De lucia Gaetano Barbagallo Orazio Schillaci 《Annals of nuclear medicine》2020,34(4):254-262
The aim of our study was to investigate the impact of the epsilon phenotype in brain glucose consumption in a population with Alzheimer’s disease. Statistical Parametric Mapping (SPM8) was used to investigate differences in brain glucose consumption (as detectable by means of 18F FDG-PET/CT) in the population examined. A total of 129 patients (72 females and 57 males) with a diagnosis of probable AD according to the NINCDS-ADRDA criteria underwent the PET/CT examination. The mean (SD) age of the patients was 70 (± 7) years; the mean Mini-Mental State Examination was 19(± 5.6). 59 expressed epsilon 4 phenotype (E4) and 70 expressed the epsilon 3 phenotype (E3). Cerebral spinal fluid amyloid, tau, and t-tau have been measured resulting equal to 367.4 (± 149.1), 584.7 (± 312.1), and 79.2(± 45.9) pg/ml, respectively. Patients with confirmed amyloid and Tau changes were classified as AD. Patients with amyloid changes but negative Tau, considered as high risk of AD, were classified as IAD. Age, sex, MMSE, scholarship, and CSF parameters were used as a covariate in the SPM analyses. We did not find significant differences in age, gender, and MMSE and CSF parameters among groups. In the analysis of the AD group as compared to AD-E3, AD-E4 subjects show a significant reduction of brain glucose consumption in inferior frontal gyrus bilaterally (BA 45, BA 47). In the analysis of the IAD group as compared to IAD-E3, IAD-E4 subjects show a significant reduction of brain glucose consumption in right in medial, middle, and superior frontal gyrus (BA10, BA11), and in left medial and middle frontal gyrus (BA10, BA11). The differences between IAD-E3 and AD-E3 and between IAD-E4 and AD-E4 (and vice versa analysis) resulted not significant. APO-e4 is related to a major involvement of the frontal cortex confirming its role of risk factor in AD, while APO-3 seems not related to a specific pattern, supporting the hypothesis of neutral/protective role in AD. 相似文献
86.
Orazio Schillaci Bruno Laganà Roberta Danieli Raffaele Gentile Luigi Tubani Luigi Baratta Francesco Scopinaro 《European journal of nuclear medicine and molecular imaging》1999,26(7):713-717
In patients with systemic lupus erythematosus, involvement of the cardiovascular system is the third leading cause of death.
However, although autopsy studies have demonstrated a high incidence of abnormalities in both the myocardium and coronary
vessels, clinical manifestations have been reported in only a small percentage of cases. The aim of this study was to evaluate
myocardial perfusion in asymptomatic lupus patients using technetium-99m sestamibi single-photon emission tomography (SPET).
Twenty-eight patients without overt cardiac involvement and risk factors were studied with 99mTc-sestamibi SPET at rest and after dipyridamole infusion. Perfusion abnormalities were detected in 18 cases: six had persistent
defects, three had reversible defects, seven had both persistent and reversible defects, and two showed rest defects which
normalized on dipyridamole images (”reverse redistribution pattern”). Coronary angiography was performed in eight patients
with positive 99mTc-sestamibi SPET, and showed normal epicardial vessels in all the cases. These results indicate that 99mTc-sestamibi SPET reveals a high prevalence (18 out of 28 patients in this study, i.e. 64%) of myocardial perfusion abnormalities
in asymptomatic lupus patients, probably due to the primary immunological damage of this autoimmune disease. In conclusion,
rest/dipyridamole 99mTc-sestamibi SPET can be a useful non-invasive method to identify subclinical myocardial involvement in systemic lupus erythematosus,
and patients potentially at risk of later cardiac events.
Received 20 November 1998 and in revised form 19 February 1999 相似文献
87.
Palumbo BT Henderson E Letson GD Cheong D 《American journal of orthopedics (Belle Mead, N.J.)》2011,40(11):579-582
Soft-tissue sarcomas (STSs) are a heterogenous group of rare malignancies that have significant lifelong implications. Accepted management options include limb-sparing surgical resection and adjuvant radiation therapy. Here we present the case of a myxoid malignant fibrous histiocytoma, now termed a myxofibrosarcoma, which recurred 21 years after primary surgical resection. To our knowledge, this is the longest documented interval between initial management and recurrence of an STS. Significant changes have been made in classification guidelines and diagnostic methods over this 2-decade period. The pathogenesis of remote recurrence of STSs remains controversial and is discussed in this report. 相似文献
88.
89.
Oguogho A Lupattelli G Palumbo B Sinzinger H 《VASA. Zeitschrift für Gef?sskrankheiten》2000,29(2):103-105
BACKGROUND: Isoprostanes and in particular 8-epi-PGF2 alpha have been claimed as a useful measure for invivo oxidation injury. While smokers show elevated 8-epi-PGF2 alpha the behaviour during quitting smoking is unknown. METHODS AND RESULTS: We determined 8-epi-PGF2 alpha in 7 healthy adults ready to quit smoking in plasma, serum and urine by means of an enzyme immunoassay after extraction and purification before quitting smoking and during a follow-up period of 4 weeks. After quitting smoking, 8-epi-PGF2 alpha shows a rapid decline within a few days almost completely normalizing within 4 weeks. CONCLUSION: The cigarette-smoking associated invivo oxidation injury almost completely disappears within 4 weeks of quitting smoking. 相似文献
90.
Bolognese A Correale G Manfra M Lavecchia A Mazzoni O Novellino E Barone V Pani A Tramontano E La Colla P Murgioni C Serra I Setzu G Loddo R 《Journal of medicinal chemistry》2002,45(24):5205-5216
The iminoquinone is an important moiety of a large number of antineoplastic drugs and plays a significant role in the nucleus of actinomycins, powerful, highly toxic, natural antibiotics that target DNA as intercalating agents. A series of polycyclic iminoquinonic compounds, 2-amino-3H-phenoxazin-3-one (1), 2-amino-1,9-diacetyl-3H-phenoxazin-3-one (2), 2-acetylamino-3H-phenoxazin-3-one (3), 3H-phenoxazin-3-one (4), 5H-pyrido[3,2-a]phenoxazin-5-one (5), and 5H-pyrido[3,2-a]phenothiazin-5-one (6), strictly related to the actinomycin chromophore, were synthesized for developing new anticancer intercalating drugs. The antiproliferative activity of these compounds, evaluated against representative human liquid and solid neoplastic cell lines, showed that 5 and its isoster 6 were the most active compounds inhibiting cell proliferation in a submicromolar range. Compound 5 was also evaluated against KB subclones (KBMDR, KB7D, and KBV20C), which overexpress the MDR1/P-glycoprotein drug efflux pump responsible for drug resistance. All the above KB subclones did not show altered sensitivity to the antiproliferative activity of 5. UV-vis and (1)H NMR spectroscopy experiments support the phenoxazinone 5/DNA binding. Molecular mechanics methods were used to build a three-dimensional model of the 5/[d(GAAGCTTC)]2 complex. Electrostatic interactions between the hydrogen of the positively charged pyridine nitrogen of 5 and the negatively charged oxygen atoms (O4' and O5') of the cytosine C5 residue together with stacking forces contribute to the high antiproliferative activity. The metal(II)-assisted synthesis procedure of 5 is described, and the formation mechanism is proposed. 相似文献